Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3107 results found
Expand All
Apply All
3107 results found

New Mexico advances clean fuel standard
Share
Good Day BIO Newsletter  •  March 10, 2021
Could New Mexico be the next state to implement a clean fuels standard? Maybe—with your help. We explain more, plus have news from the Capitol on the COVID-19 response and the patent gap. (1,050 words, 5 minutes, 15 seconds)
Read More

How we can boost access to COVID vaccines and treatments
Share
Good Day BIO Newsletter  •  March 9, 2021
BIO’s Dr. Michelle McMurry-Heath explains how we can boost access to COVID-19 vaccines and treatments—around the world and right here at home. And since everyone’s talking about tackling climate change and building resiliency, we explain how biotech can help. (819 words, 4 minutes, 5 seconds)
Read More

Patient Experience Data Throughout Medical Product Development and Review
Share
Patient Advocacy, Biotech Basics  •  Toolkit  •  March 9, 2021
Patient Experience Data is the systematic collection of meaningful data related to the experiences, perspectives, needs, and priorities of patients. Below you will find a graphic that outlines types of patient experience data, how that data might be used in different phases of drug development and review.
Read More

Letter to President Biden Discusses Collaboration To Boost Access to COVID-19 Treatments
Share
Intellectual Property, Patents, Cost & Value of Biopharmaceuticals  •  Press Release  •  March 8, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Biden outlining ways the public and private sectors can best work with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics.   The letter, written on behalf of BIO members, highlights the importance of the COVAX and “ACT-Accelerator” initiatives to increase global vaccine access. It also makes clear industry concerns about the proposed “TRIPS waiver” in helping end this pandemic: Dr. McMurry-Heath writes the TRIPs waiver would “distract from the need for coordinated international efforts and the cooperative work that currently is being advanced, and thus ultimately undermine the very goals of quick, safe access that it seeks to promote.” She further notes:   “The global pandemic can only be ended with global efforts that reach everywhere this deadly virus is prevalent […] BIO strongly supports strong, efficient, and effective efforts to see that successful COVID products get to patients everywhere in the world that need them. “BIO looks forward to continuing its work with the Administration and other parties in developing policies that address global access considerations to COVID treatments and vaccines while also continuing to support innovative biotech research and development endeavors aimed at bringing this pandemic to an end as soon as possible.” Read the full letter here or below.
Read More
Letter to President Biden Discusses Collaboration To Boost Access to COVID-19 Treatments

BIO Sends Letter to President Biden Discussing Collaboration to Ensure Patient Access to COVID Treatments
Share
Letters, Testimony & Comments  •  March 8, 2021
BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics.
Read More

What biotech should know about the COVID relief package
Share
Good Day BIO Newsletter  •  March 8, 2021
ICYMI: The Senate passed the COVID-19 relief package, which heads back to the House for a final vote this week. We tell you a few provisions you need to know. We also celebrate International Women’s Day with pioneering Chinese-American nuclear physicist Chien-Shiung Wu and a few modern day biotech “sheroes.” (1,000 words, 5 minutes)
Read More

National and Local Companies Form New Mexico Clean Fuels Coalition to Support Diversification of State's Economy
Share
Agriculture & Environment, Sustainable Fuels, Climate Change  •  Press Release  •  March 5, 2021
Albuquerque, NM (March 5, 2021) – In response to New Mexico’s proposed Clean Fuel Standard legislation, 21 national and New Mexico-based companies and organizations formed the New Mexico Clean Fuel Coalition to support the state’s efforts to diversify New Mexico’s economy while decreasing greenhouse gas emissions. The Coalition was formed in conjunction with the Low Carbon Fuels Coalition, a national organization that plays a leading role in helping shape clean fuel policy at state and national levels. If enacted, the Clean Fuel Standard Act, SB 11, would establish a market-based approach to cut greenhouse gas emissions from transportation fuels, requiring fuel producers and importers to reduce the amount of carbon in fuels used in New Mexico —a 10% reduction by 2030 and a 28% reduction by 2040. Fuel producers and importers can meet the reduction goals by purchasing credits if they are not able to produce sufficiently low-carbon fuels. Credits may be generated from any business in any sector of New Mexico’s economy – including the agriculture, chemical, dairy, energy, forestry, manufacturing, mining, oil and gas, waste management and wastewater treatment industries. “This proposed legislation aligns with the Coalition’s mission to support market-based clean fuel policies in the United States,” said Graham Noyes, Executive Director of the Low Carbon Fuels Coalition. “We are excited about this new business coalition forming in New Mexico and look forward to working with the Governor and her leadership team on this legislation and on future clean fuel policies.” Adelante Consulting, Inc., is coordinating efforts of the New Mexico Fuels Coalition. Adelante is a New Mexico-based firm with expertise in market-based trading programs and a member of the Low Carbon Fuels Coalition. Adelante Consulting identified the adoption of a low carbon fuel standard in New Mexico as a key policy prerequisite to attract bio-based industry to the state in a feasibility study for…
Read More

What’s happening in the state legislatures
Share
Good Day BIO Newsletter  •  March 5, 2021
While we’re waiting for news from the Senate on the COVID-19 relief package, we caught up with Patrick Plues, BIO’s VP of State Government Affairs, to get an update on the state legislatures and some of the 600+ bills BIO’s tracking and engaging on covering health care, agriculture, and economic development. (1205 words, 6 minutes)
Read More

Why Biden’s pandemic agenda cannot ignore superbugs
Share
Good Day BIO Newsletter  •  March 4, 2021
Today, Dr. Michelle tells us why we must not ignore superbugs as we prepare for future pandemics. Also, we have news about LanzaTech’s new partnership to make perfume more sustainable, and an announcement about BIO Digital 2021. (671 words, 3 minutes, 21 seconds)
Read More

BIO Supports Emergency Relief for Black Farmers as Part of COVID Relief
Share
Agriculture & Environment, Climate Change  •  Letters, Testimony & Comments  •  March 3, 2021
The Biotechnology Innovation Organization (BIO) applauds the introduction of the Emergency Relief for Farmers of Color Act and welcomes the inclusion of provisions from this legislation in the American Rescue Plan.  BIO is committed to championing broad access to biotech breakthroughs and scientific equality and welcomes the opportunity to work with Congress and the Administration to meet the challenges of inequity head on.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 188
  • 189
  • 190
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO